Replies to post #444045 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I don’t feel like doing any more work than this.

nor did I ask you to

Thank your for the article.

However, many drugmakers announce when they receive a PDUFA date from the agency for one of their drugs. Such announcements can be major catalysts, especially for small pharmaceutical, vaccine, or biotech stocks.

as I was saying not saying anything about PDUFA or Topline data would make NWBO unique. Not impossible but unique.

Often companies have the final draft label minus minor grammatical tweaks well ahead of receiving the approval letter. They already know the answer but it isn’t official and they can’t and don’t leak this information. They can line up contracts and all thing necessary to launch. They can even print material “at risk.” How else do you think product can be available on Monday after receiving the letter on Friday?

and these companies you speak of before that never shared any topline data with the public? Cause that was my question/remark.